Blog
International Women's Day: Celebrating Sonia Nabeta
7 Mar 2017, 10:47 a.m. in Global Stories by Vivian Nabeta
In the world of Type 1 diabetes (T1D), “warriors” are the valiant people living with this chronic condition. Sonia Nabeta was one such warrior, who for 16 years believed that her T1D diagnosis was a gift. Until her earthly candle was snuffed out in August 2015, she was convinced that T1D knocked on her door to sharpen attributes that otherwise would have lain dormant! She credited this ailment for many of her salient qualities, especially her diligence and discipline but most of all her compassion. Read more
The Cold Cost of American Capitalism
1 Mar 2017, 5:17 p.m. in #insulin4all USA, Global Stories by Charles Murphy
My life is a roller coaster ride of uncertainty. I just want the tools I need to manage my life and to experience a semblance of happiness. Instead, I am squabbling with insurance and pharmaceutical companies to provide the care that I believe is my natural human right. The injustices experienced by type 1 diabetics in this country amount to a form of massacre. Read more
Diabetes and the “American Dream”
20 Feb 2017, 10:31 a.m. in #insulin4all USA, Global Stories by Karyn Wofford
I was diagnosed with type 1 diabetes when I was 12, after my mom noticed I had lost an extreme amount of weight after three days at summer camp. She had my uncle, a type 2 diabetic test my blood sugar, like he had many times before because of my fascination with medical equipment. Except this time, something was wrong. Read more
America is Number 1 - in Diabetes Costs
15 Feb 2017, 10:39 a.m. in #insulin4all USA, Global Stories by James Elliott
Everyone likes being #1, and Americans are no exception. Few Americans will be celebrating that they have the world’s highest out of pocket costs for insulin and other life-saving diabetes supplies. Read more
An update on Insulin for Syrians
8 Feb 2017, 7:17 p.m. in Global Stories, News & Statements by Elizabeth Pfiester
Many of you supported T1International’s Insulin for Syrians campaign last year, when we raised funds for our partner organisation, the Syrian American Medical Society (SAMS) to ensure that people living with diabetes amidst the crisis in Syria would be able to have access to insulin and basic supplies. Read this update about the situation now and how your donation helped. Read more
Patients vs. Pharma: Hagens Berman files complaint against 'Big Three' insulin producers
30 Jan 2017, 9:15 p.m. in #insulin4all USA, News & Statements by T1International
The law firm Hagens Berman has filed a complaint against Eli Lilly, Novo Nordisk, and Sanofi, the ‘big three’ pharmaceutical companies that hold a near-monopoly on the insulin market. People living with type 1 diabetes will be the plaintiffs in this class action lawsuit, which alleges that Eli Lilly, Novo Nordisk and Sanofi have unjustly inflated their prices. Read more
Supporting Refugees with type 1 diabetes in Germany
23 Jan 2017, 4:51 p.m. in Global Stories by Katarina Braune
When refugees arrive in Germany and apply for asylum, the registration office and the doctors of Berlin’s refugee health department are the first people they meet. Oftentimes it is their first opportunity to see a health care professional in weeks or even months. During the past two years our health care system here in Germany has been overwhelmed by the large amount of immigrants coming to Europe. Many refugees got sick on their long and exhausting trip... Read more
T1International Year in Review: 2016
10 Jan 2017, 12:13 p.m. in News & Statements by T1International
What did T1International achieve in 2016? Lots! We raised funds to get insulin to Syrians in need, we carried out our Insulin & Supply survey to show how unaffordable type 1 diabetes really is, we launched the Type 1 Access Charter as well as the Advocacy toolkit, and so much more! Read more
Diabetes in Russia
1 Jan 2017, 3:09 p.m. in Global Stories by Hazel Hughes
Last February, I had the opportunity to leave my rural Cheshire home for a week to travel to Moscow. While there, I met with 3 women with diabetes. We shared stories and compared experiences, and my eyes were opened to the vastly different challenges that they face. Read more
Eli Lilly and Novo Nordisk: More Empty Promises
19 Dec 2016, 9:01 a.m. in #insulin4all USA, News & Statements by Elizabeth Pfiester
Outrage at soaring insulin prices in the USA has been increasing. More patients and families are speaking out against unaffordable costs for life-saving medication than ever before. In response, two of the 'Big Three' insulin makers (who control over 90% of the insulin market) have recently made moves to combat this anger. Read more